Ketamine hydrochloride, commonly appearing as a white crystalline solid or powder, is a dissociative anesthetic first synthesized in 1962 by Calvin Stevens at Parke-Davis. It was initially developed as a safer alternative to phencyclidine (PCP) for human and veterinary anesthesia, receiving FDA approval in 1970 under the brand name Ketalar. By 2026, ketamine remains one […]
Introduction: The Rise of Ketamine in Mental Health Treatment Depression affects millions globally, often resisting conventional treatments like antidepressants and psychotherapy. Recently, ketamine has emerged as a novel option that offers rapid relief for many individuals struggling with treatment-resistant depression. Ketamine is traditionally known as an anesthetic and sometimes misused recreationally, but its clinical potential […]